Conference Agenda

10th Annual BFC HealthCare Conference

Sunday, January 10, 2027 -- The St. Regis San Francisco

  • TIME
    Sunday, January 10, 2027
  • 08:00 – 09:00
    Registration
  • 09:00 – 09:15
    Opening Remark
  • 09:15 – 09:40
    Fireside Chat I – Global Biopharma at an Inflection Point – Strategy, Innovation & Growth
    Moderator:
    David Chen, Founder & Managing Director, BFC Group
    Featured Speaker:
    Wendy Cheung, Senior Vice President, Therapeutic Area Head Oncology Hematology, Global Pharma Strategy, Roche
  • 09:40 – 10:40
    Capital in Motion – The Global Biotech Investment Landscape
    Distinguished Speakers:
    David Wang, Partner, Senior Managing Director of OrbiMed Asia, OrbiMed
    Frank Nestle, Partner, Deerfield | CEO, 3DC
    Kevin Chen, Founding Partner & CEO, BioTrack Capital
    Ricky Sun, Partner, Bain Capital Life Sciences
  • 10:40 – 11:00
    Coffee Break
  • 11:00 – 11:25
    Fireside Chat II
  • 11:25 – 12:25
    The Global Pharma Agenda – Competing for Breakthrough Innovation
    Distinguished Speakers:
    Markus Werner, Head, Search & Evaluation Oncology, Novartis
    Johan Verbeeck, Vice President, Business Development, Oncology, Johnson & Johnson Innovative Medicine
    Michelle Li, Senior Vice President, Head of Business Development, Alnylam Pharmaceuticals
    Fan Zhang, VP, Search and Evaluation, Business Development, Bristol Myers Squibb
    Enza Di Modugno, Global Head of CVRM, Immunology & Infectious Diseases, Corporate Business Development, Roche
  • 13:35 – 14:00
    Fireside Chat III – From Asset to Company – The NewCo Creation Playbook
    Moderator:
    Shirley Lu, Managing Director, BFC Group
    Featured Speaker:
    Ken Song, Venture Partner, Venrock
  • 14:00 – 15:00
    Beyond Today's Priorities – Where Pharma Sees the Next Wave of Growth
    Distinguished Speakers:
    Rene Fuertig, Head of Neuroscience and Eye Health BD+L, Boehringer Ingelheim
    Neville Mehenti, Head of Oncology Corporate Development at Gilead Sciences
    Guillaume Vignon, Global Head BD&L Transactions, Novartis Pharma AG
    Dushen Chetty, Development Head, Breast and GU Cancers, Pfizer
    Tomohiro Yamauchi, Head of Scouting & Transaction Oncology, Business development, Astellas
  • 15:00 – 15:15
    Keynote Speech – Function-direct AI therapeutic design
    Featured Speaker:
    Eason Lin, Associate Director, Aureka Biotechnologies
  • 15:15 – 16:15
    Targeting tomorrow – AI and the future of Drug Discovery
    Moderator:
    Weian Zhao, CEO, Aureka Biotechnologies
    Distinguished Speakers:
    Sandy Li, Head of Discovery Partnerships, AI, AbbVie
    Alexandria Cogdill, Head Strategic Initiatives, Global BD, Daiichi Sankyo
    Karsten Kreis, Principal Research Scientist, NVIDIA
  • 16:15 – 17:15
    The R&D Frontier – Science, Technology & the Future of Medicines
    Distinguished Speakers:
    Clark Pan, VP, Biotherapeutics & Genetic Medicine Technologies, AbbVie
    Jiye Shi, Senior Vice President, Small Molecule Discovery, Eli Lilly
    Stephen Pitt, VP, Head of Search & Evaluation, R&D, CSL
    Navin Rao, Global Head Discovery Immunology, Johnson & Johnson
More panelists to be announced
Register